Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture

International Journal of Antimicrobial Agents

Volumn 33, Issue 1, 2009, Pages 14-20

  Franzman, Michael R ^a   Burnell, Kindra K ^a   Dehkordi Vakil, Farideh H ^b   Guthmiller, Janet M ^c   Dawson, Deborah V ^a   Brogden, Kim A ^a  

^a UNIVERSITY OF IOWA   (United States)

^b WESTERN ILLINOIS UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Aggregatibacter actinomycetemcomitans; Cathelicidins; Peptostreptococcus micros; Porphyromonas gingivalis; SMAP28; Targeted antimicrobial activity

Indexed keywords

ANTIBODY CONJUGATE; IMMUNOGLOBULIN G; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN G; RABBIT ANTISERUM; SHEEP MYELOID ANTIMICROBIAL PEPTIDE 28; UNCLASSIFIED DRUG;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROORGANISM; NONHUMAN; PEPTOSTREPTOCOCCUS MICROS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIMICROBIAL CATIONIC PEPTIDES; CROSS-LINKING REAGENTS; CULTURE MEDIA; ECOSYSTEM; HUMANS; IMMUNOGLOBULIN G; MALEIMIDES; MICROBIAL SENSITIVITY TESTS; PASTEURELLACEAE; PEPTOSTREPTOCOCCUS; PORPHYROMONAS GINGIVALIS; SHEEP;

EID: 59349093299     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.05.021     Document Type: Article

References (38)

1. Bud R. Antibiotics: the epitome of a wonder drug. BMJ 334 Suppl. 1 (2007) s6
2. Khardori N. Antibiotics-past, present, and future. Med Clin North Am 90 (2006) 1049-1076
3. Rice L.B., Sahm D., and Bonomo R.A. Mechanisms of resistance to antibacterial agents. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of clinical microbiology. 8th ed. (2003), ASM Press, Washington, DC pp. 1074-101
4. Smith D.L., Harris A.D., Johnson J.A., Silbergeld E.K., and Morris Jr. J.G. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci USA 99 (2002) 6434-6439
5. Gleckman R.A., and Borrego F. Adverse reactions to antibiotics. Clues for recognizing, understanding, and avoiding them. Postgrad Med 101 (1997) 97-98 101-4, 107-8
6. Yao J.D.C., and Moellering R.C. Antibacterial agents. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of clinical microbiology. 8th ed. (2003), ASM Press, Washington, DC pp. 1039-73
7. Slots J., and Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000 28 (2002) 106-176
8. Preshaw P.M. Systemic antibiotics in the management of chronic periodontitis. Eur J Prosthodont Restor Dent 12 (2004) 63-69
9. Haffajee A.D., Socransky S.S., and Gunsolley J.C. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 8 (2003) 115-181
10. Herrera D., Sanz M., Jepsen S., Needleman I., and Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 29 Suppl. 3 (2002) 136-159
11. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 3 (2005) 238-250
12. Hancock R.E., and Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24 (2006) 1551-1557
13. Marr A.K., Gooderham W.J., and Hancock R.E. Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6 (2006) 468-472
14. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
15. Groisman E.A. How bacteria resist killing by host-defense peptides. Trends Microbiol 2 (1994) 444-448
16. Gunn J.S. Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotoxin Res 7 (2001) 57-62
17. Peschel A., Otto M., Jack R.W., Kalbacher H., Jung G., and Gotz F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274 (1999) 8405-8410
18. Roland K.L., Esther C.R., and Spitznagel J.K. Isolation and characterization of a gene, pmrD, from Salmonella typhimurium that confers resistance to polymyxin when expressed in multiple copies. J Bacteriol 176 (1994) 3589-3597
19. Perron G.G., Zasloff M., and Bell G. Experimental evolution of resistance to an antimicrobial peptide. Proc Biol Sci 273 (2006) 251-256
20. Schubert C. Microbes overcome natural antibiotic. Might we create superbugs that resist our bodies' ancient defences?. Nature news (2005), Nature Publishing Group, London, UK
21. Shelburne C.E., Coulter W.A., Olguin D., Lantz M.S., and Lopatin D.E. Induction of β-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother 49 (2005) 183-187
22. Guthmiller J.M., Vargas K.G., Srikantha R., Schomberg L.L., Weistroffer P.L., McCray Jr. P.B., et al. Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob Agents Chemother 45 (2001) 3216-3219
23. Joly S., Maze C., McCray Jr. P.B., and Guthmiller J.M. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 42 (2004) 1024-1029
24. Zagursky R.J., Ooi P., Jones K.F., Fiske M.J., Smith R.P., and Green B.A. Identification of a Haemophilus influenzae 5′-nucleotidase protein: cloning of the nucA gene and immunogenicity and characterization of the NucA protein. Infect Immun 68 (2000) 2525-2534
25. Kalfa V.C., Jia H.P., Kunkle R.A., McCray Jr. P.B., Tack B.F., and Brogden K.A. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother 45 (2001) 3256-3261
26. Hansen C.J., Burnell K.K., and Brogden K.A. Antimicrobial activity of substance P and neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J Neuroimmunol 177 (2006) 215-218
27. Steinberg D.A., and Lehrer R.I. Designer assays for antimicrobial peptides. Disputing the 'one-size-fits-all' theory. Methods Mol Biol 78 (1997) 169-186
28. Peschen D., Li H.P., Fischer R., Kreuzaler F., and Liao Y.C. Fusion proteins comprising a Fusarium-specific antibody linked to antifungal peptides protect plants against a fungal pathogen. Nat Biotechnol 22 (2004) 732-738
29. Qiu X.Q., Wang H., Lu X.F., Zhang J., Li S.F., Cheng G., et al. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria. Nat Biotechnol 21 (2003) 1480-1485
30. Qiu X.Q., Zhang J., Wang H., and Wu G.Y. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 49 (2005) 1184-1189
31. Simpson W., Olczak T., and Genco C.A. Characterization and expression of HmuR, a TonB-dependent hemoglobin receptor of Porphyromonas gingivalis. J Bacteriol 182 (2000) 5737-5748
32. Kataoka K., Amano A., Kuboniwa M., Horie H., Nagata H., and Shizukuishi S. Active sites of salivary proline-rich protein for binding to Porphyromonas gingivalis fimbriae. Infect Immun 65 (1997) 3159-3164
33. Amano A., Shizukuishi S., Horie H., Kimura S., Morisaki I., and Hamada S. Binding of Porphyromonas gingivalis fimbriae to proline-rich glycoproteins in parotid saliva via a domain shared by major salivary components. Infect Immun 66 (1998) 2072-2077
34. Amano A., Nakamura T., Kimura S., Morisaki I., Nakagawa I., Kawabata S., et al. Molecular interactions of Porphyromonas gingivalis fimbriae with host proteins: kinetic analyses based on surface plasmon resonance. Infect Immun 67 (1999) 2399-2405
35. Chung W.O., Demuth D.R., and Lamont R.J. Identification of a Porphyromonas gingivalis receptor for the Streptococcus gordonii SspB protein. Infect Immun 68 (2000) 6758-6762
36. Hellstrom U., Hallberg E.C., Sandros J., Rydberg L., and Backer A.E. Carbohydrates act as receptors for the periodontitis-associated bacterium Porphyromonas gingivalis: a study of bacterial binding to glycolipids. Glycobiology 14 (2004) 511-519
37. Kalfas S., Andersson M., Edwardsson S., Forsgren A., and Naidu A.S. Human lactoferrin binding to Porphyromonas gingivalis, Prevotella intermedia and Prevotella melaninogenica. Oral Microbiol Immunol 6 (1991) 350-355
38. Tack B.F., Sawai M.V., Kearney W.R., Robertson A.D., Sherman M.A., Wang W., et al. SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 269 (2002) 1181-1189